Inhibitory Effects of Elevated Temperature on Human Cytokine Production and Natural Killer Activity

Cancer Research

Volumn 46, Issue , 1986, Pages 6236-6241

  Dinarello, Charles A ^a   Dempsey, Roy A ^a   Allegretta, Mark ^a   LoPreste, Gail ^a   Parkinson, David R ^a   Mier, James W ^a   Dainiak, Nicholas ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COLONY STIMULATING FACTOR; CYTOKINE; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 2;

BLOOD AND HEMOPOIETIC SYSTEM; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; THERAPY; TUMOR IMMUNITY;

BIOLOGICAL PRODUCTS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HEAT; HUMANS; INTERFERONS; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-3; KILLER CELLS, NATURAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0022835376     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Nauts, H.C. Bacterial products in the treatment of cancer: past, present, and future. In: J. Jeljaszewicz, G. Pulverer, and W. Roskowski (eds.), Bacteria and Cancer, pp. 1-27. New York: Academic Press, 1982.
2. Coley, W.B. Further observations on the conservative treatment of sarcoma of the long bones. Ann. Surg., 70:633-660, 1919.
3. Miller, T.R., and Nicholson, J.T. End results in reticulum cell sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and/ or radiotherapy (47 cases) or with concurrent infection (5 cases). Cancer (Phila.), 27: 524-548, 1971.
4. Uchida, A., and Hoshimo, T. Reduction of suppressor cells in cancer patients treated with OK-432 immunotherapy. Int. J. Cancer, 26:401-412, 1980.
5. Hall, E.J., and Roizin-Towle, L. Biological effects of heat. Cancer Res., 44: 4708s-4713s, 1984.
6. Li, D.J., and Hahn, G.M. Responses of RIF tumors to heat and drugs: dependence on tumor size. Cancer Treat. Rep., 68:1149-1151, 1984.
7. Andreesen, R., Osterholtz, J., and Schultz, A. Enhancement of spontaneous and lymphokine activated human macrophage cytotoxicity by hyperthermia. Blut, 47:225-229, 1983.
8. Roberts, N.J., Jr., and Steigbigel, R.T. Hyperthermia and human leukocyte functions: effects on response of lymphocytes to mitogen and antigen and bactericidal capacity of monocytes and neutrophils. Infect. Immun., 16:947-954, 1977.
9. Roberts, N.J., Jr. Temperature and host defense. Microbiol. Rev., 43: 241-259, 1979.
10. Wilkinson, P.C. Chemotaxis and Inflammation. Edinburgh: Churchill Livingston, 1982.
11. Duff, G.W., and Durum, S.K. Fever and immunoregulation: hyperthermia, interleukin-1 and 2, and T-cell proliferation. Yale J. Biol. Med., 55: 437-442, 1982.
12. Duff, G.W., and Durum, S.K. The pyrogenic and mitogenic actions of interleukin-1 are related. Nature (Lond.), 304:449-451, 1983.
13. Hanson, D.F., Murphy, P.A., Silicano, R., and Shin, H.S. The effect of temperature on the activation of thymocytes by interleukins 1 and 2. J. Immunol., 130:216-221, 1983.
14. Muellbacher, A. Hyperthermia and the generation of and activity of murine influenza-immune cytotoxic T cells in vitro. J. Virol., 52:928-931, 1984.
15. Dinarello, C.A. Interleukin-1. Rev. Infect. Dis., 6:51-95, 1984.
16. Dempsey, R.A., Dinarello, C.A., Mier, J.W., Rosenwasser, L.J., Allegretta, M., Brown, T.E., and Parkinson, D.R. The differential effects of human leukocytic pyrogen/lymphocyte activating factor, T-cell growth factor, and interferon on human natural kier cell activity. J. Immunol., 129: 2504-2510, 1982.
17. Herberman, R.B. Natural killer cells and their possible roles in resistance against disease. Clin. Immunol. Rev., 1: 1-65, 1981.
18. Horning, S.J., Levine, J.D., Miller, R.A., Rosenberg, S.A., and Merigan, T.C. Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer. J. Am. Med. Assoc., 247:1718-1722, 1982.
19. Lotze, M.T., Frana, L.W., Sharrow, S.O., Robb, R.J., and Rosenberg, A.S. In vivo administration of purified human interleukin-2. J. Immunol., 134: 157-166, 1985.
20. Pulley, M., Dumonde, D., Carter, G., Muller, B., Southcott, B., and Hollander, F. Lymphokines as mediators of extrinsic immunoregulatory circuits. In: J. J. Oppenheim and S. Cohen (eds.), Interleukins, Lymphokines, and Cytokines, pp. 723-730. New York: Academic Press, 1982.
21. Dinarello, C.A., Renfer, L., and Wolff, S.M. Human leukocytic pyrogen: purification and development of a radioimmunoassay. Proc. Natl. Acad. Sci. USA, 74:4626-4627, 1977.
22. Hanson, D.F., and Murphy, P.A. Demonstration of interleukin-1 activity in apparently homogeneous specimens of the pI 5 form of rabbit endogenous pyrogen. Infect. Immun., 45:483-490, 1984.
23. Dinarello, C.A., Bemheim, H.A., Cannon, J.G., Lopreste, G., Warner, S.J.C., Webb, A.C., and Auron, P.E. Purified, S-met, H-Leu-labelled human monocyte interleukin-1 (IL-1) with endogenous pyrogen activity. Br. J. Rheum., 24:59-64, 1985.
24. Mier, J.W., and Gallo, R.C. Purification and some characteristics of human T-cell growth factor (TCGF) from PHA-stimulated lymphocyte conditioned media. Proc. Natl. Acad. Sci. USA, 77:6134-6138,1980.
25. Dainiak, N., Davies, G., Kalmanti, M., Lawler, J., and Kulkarni, V. Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro. J. Clin. Invest., 71: 1206-1214, 1983.
26. Pike, B.L., and Robinson, W.A. Human bone marrow colony growth in agar gel. J. Cell. Physiol., 76: 77-84,1970.
27. Krensky, A.M., Reiss, C.S., Mier, J.W., Strominger, J.L., and Burakoff, S.J. Long term human cytolytic T-cell lines allospecific for HLA-DR 6 antigen are OKT4. Proc. Natl. Acad. Sci. USA, 79:2365-2369, 1982.
28. Baracos, V., Rodemann, H.P., Dinarello, C.A., and Goldberg, A.L. Stimulation of muscle protein degradation and prostaglandin Erelease by leukocytic pyrogen (interleukin-1). N. Engl. J. Med., 308: 553-558,1983.
29. Ortaldo, J., and Herberman, R. Heterogeneity of natural killer cells. Annu. Rev. Immunol., 2: 359-394, 1984.
30. Jampel, H.D., Duff, G.W., Gershon, R.K., Atkins, E., and Durum, S.K. Fever and immunoregulation. J. Exp. Med., 157: 1229-1238, 1983.
31. Dinarello, C.A., Bernheim, H.A., Duff, G.W., Le, H.V., Nagabhushan, T.L., Hamilton, N.C., and Coceani, F. Mechanisms of fever induced by recombinant human interferon. J. Clin. Invest. 74:906-913, 1984.
32. Ron, Y., Dougherty, J.P., Duff, G.W., and Gershon, R.K. The effects of febrile temperatures on biologic actions of interferons: abrogation of suppression of delayed-type hypersensitivity and antibody production. J. Immunol., 133:2037-2042, 1984.
33. Girard, D.J., Fleischaker, R.J., and Sinskey, A.J. Kinetics of human beta interferon production under different temperature conditions. Interferon Res., 2:471-477, 1982.
34. Belardelli, F., Vignaux, F., Proietti, E., and Gresser, I. Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus. Proc. Natl. Acad. Sci. USA, 81:602-606, 1984.
35. Granelli-Pipemo, A., Andrus, L., and Reich, E. Antibodies to interleukin-2. Effects on immune responses in vitro and in vivo. J. Exp. Med., 160: 738-751, 1984.
36. Gresser, I., Belardelli, F., Maury, C., Maunoury, M., and Tovey, M. Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors. J. Exp. Med., 158:2905-2912, 1983.
37. Bloom, B.R. Natural killers to rescue immune surveillance? Nature (Lond.), 300:214-215, 1982.
38. Kalland, T., and Dahlquist, I. Effects of in vitro hyperthermia on human natural killer cells. Cancer Res., 43: 1842-1846,1983.
39. Maytin, E.V., and Young, D.A. Separate glucocorticoid, heavy metal, and heat shock domains in thymic lymphocytes. J. Biol. Chem., 258: 12718-12722, 1983.
40. Morimoto, R., and Fodor, E. Cell-specific expression of heat shock proteins in chickens reticulocytes and lymphocytes. J. Cell. Biol., 99: 1316-1323, 1984.
41. Yang, H.K., Cain, C.A., Lockwood, J., and Tompkins, W.A. Effects of microwave exposure on the hamster immune system. I. Natural killer cell activity. Bioelectromagnetics, 4: 123-139,1983.
42. Nurmi, T., Uhari, M., and Kouvalainen, K. Temperature and natural killer cell activity. Lancet, 1: 16-17, 1982.
43. Zaenker, K.S., and Lange, J. Whole body hyperthermia and natural killer cell activity. Lancet, 1: 1079-1080, 1982.